The psychedelic therapy small-cap stocks Psyence Biomedical and Enveric continued to fall in this wave 😭 Psyence dropped 16%. It seems SciSparc's rebound didn't lift the entire sector.
The polarization in the psychedelic drug sector is quite clear. Only stocks with concrete pipeline progress can rise; those without catalysts just get tossed around by sector sentiment. Highly speculative instruments, remember to keep positions light.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
